CH3100 - Molecular Basis of Therapeutics 4
|Student Contribution Band:
||College of Science and Engineering
Available to students who are enrolled in the BPharm, BPharm IHCAP Program and the
BPharm Honours Programs.
This subject will examine the medicinal chemistry relevant to the process of drug
discovery and development as practised in the modern pharmaceutical industry. Building
on the material covered in second year, it will develop in students a knowledge of
the research tools which are applied in the drug discovery process. Topics in this
subject may include: high throughput screening, computational chemistry and molecular
modelling, QSAR, combinatorial synthesis techniques, pharmaceutical degradation and
the use of natural products or derivatives thereof in pharmaceuticals.
- explain routes of pharmaceutical degradation and solve model problems on the kinetics
of this process;
- employ preparative techniques to synthesise model pharmaceuticals and undertake their
analysis in a practical setting;
- discuss modern strategies used in the drug discovery and development process;
- assess the role chemical functionalities of a drug molecule and their changes have
on its pharmacodynamics and pharmacokinetics;
- identify natural products classes and explain their role in the drug discovery process.
||BC2014 and PC2002 and PC2004 and PC2006 and HS2401 and PC2001 and PC2003 and PC2201.
Study Period 2
|Census Date 29-Aug-2019
||Dr Mark Robertson
||Assoc. Professor Michael Oelgemoeller, Dr Mark Robertson.
The student workload for this
credit point subject is approximately
- 36 hours on-campus > Lectures
- 3 hours on-campus > Tutorials - 3 x 1 hour tutorials
- 24 hours on-campus > Practicals - 6 x 4 hour pracs
- assessment and self-directed study
||end of semester exam (70%); practicals (30%).
Minor variations might occur due to the continuous Subject quality improvement process,
and in case
of minor variation(s) in assessment details, the Subject Outline represents the latest